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Summary. Dysregulation of the epidermal growth factor 
receptor (EGFR) is one of the most frequently studied 
molecular events leading to oral carcinogenesis. Over- 
expression of EGFR is a common event in many human 
solid tumors. Elevated levels of EGFR mRNA in human 
cancer occur with and without gene rearrangement. 
Structural alterations in the receptor can also result in the 
dysregulation of the EGFR pathway. EGFR over- 
expression without gene re-arrangement is frequently 
observed in human oral cancers. However, little is 
known whether structural alterations in the receptor or 
perturbations in the EGFR pathway contribute to oral 
carcinogenesis. Several preliminary studies suggest that 
EGFR-targeted therapeutic approaches might be 
successful in controlling oral cancer. 
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Introduction 
Cancer of the oral cavity represents the sixth most 
common malignancy worldwide (Sidransky, 1995; 
Silverman, 1998). In some populations, oral cancer 
accounts for greater than 50% of all newly diagnosed 
malignancies. Approximately half of the patients 
afflicted will die within five years of diagnosis, while 
surviving patients may be left with severe esthetic andtor 
functional compromise (Silverman, 1998). Carcinomas 
account for 96% of all oral cancers, and 91% of which 
are squamous cell carcinomas (Parkin et al., 1988). 
Therefore, the oral cancer problem primarily consists of 
the biology, diagnosis and management of squamous cell 
carcinomas. Advances in understanding the underlying 
mechanisms of oral carcinogenesis will likely be 
necessary to improve patient survival curves which, 
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Histopathology 
despite better early detection of oral cancer, have 
plateaued over the past two decades and remain among 
the worse of all cancer sites (Parkin et al., 1988; 
Schantz,  1993, Kim and Shin, 1997). While the 
molecular mechanisms of oral carcinogenesis are poorly 
understood, recent advances in understanding the 
epidermal growth factor receptor (EGFR) may have 
important implications in the biology, diagnosis and 
management of oral cancer. 
The EGFR pathway is among the most extensively 
studied models in tumor biology, providing one of the 
first links between an activated oncogene and human 
tumor formation (Downward et al., 1984). EGFR is a 
member of the tyrosine kinase receptor superfamily (Fig. 
1). These tyrosine kinases are widely believed to play an 
important role in embryonic development, wound 
healing and carcinogenesis (Aaronson, 1991). Human 
EGFR is highly homologous to the viral oncogene v- 
erbB, which is carried by the avian erythroblastosis virus 
(Downward et al., 1984). The EGFR or erbB subfamily 
of the tyrosine kinase receptors is characterized by an 
extracellular ligand binding domains, transmembrane 
domains and tyrosine kinase-bearing cytoplasmic 
domains. The erbB subfamily includes erbBl (EGFR), 
erbB2 (HER2 or neu), erbB3 and erbB4 (Downward et 
al., 1984; Schechter et al., 1985; Kraus et al., 1989) (Fig. 
2A). EGFR has been found to be mutated and/or over- 
expressed in a variety of human tumors concomitantly 
with overexpression of one or more of its ligands 
(Gullick, 1991). Recent investigations have focused on 
clinical use of EGFR as a biomarker and target for 
- 
immunotherapy. 
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